( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
445.15
506.1
494.95
264.2
Total Expenditure
507.21
443.03
539.64
405.07
PBIDT (Excl OI)
-62.06
63.07
-44.69
-140.87
Other Income
10.36
3.19
3.71
4.54
Operating Profit
-51.7
66.26
-40.98
-136.33
Exceptional Items
NA
NA
NA
NA
PBDT
-82.4
64.18
-42.62
-136.71
Depreciation
58.31
23.92
17.79
-6.52
Profit Before Tax
-140.71
40.26
-60.41
-130.19
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-140.71
40.26
-60.41
-130.19
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-140.71
40.26
-60.41
-130.19
Minority Interest
NA
NA
NA
NA
Shares of Associates
-179.04
-225.7
-5.21
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-319.75
-185.43
-65.61
-130.18
Equity Capital
540.11
540.11
534.45
463.59
Calculated EPS
-2.96
-1.71
-0.61
-1.40
Calculated EPS (Annualised)
-11.84
-6.86
-2.45
-5.61
No of Public Share Holdings
56837789
56841193
55743699
48449333
% of Public Share Holdings
52.62
52.62
52.15
52.25
PBIDTM% (Excl OI)
-13.94
12.46
-9.02
-53.31
PBIDTM%
-11.61
13.09
-8.27
-51.60
PBDTM%
-18.51
12.68
-8.61
-51.74
PBTM%
-31.60
7.95
-12.20
-49.27
PATM%
-31.60
7.95
-12.20
-49.27